Last 12 months
Inside the activity.
4 purchase rows · 41 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 12 |
| Dec 2025 | 0 | 18 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 0 |
| May 2026 | 3 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 09, 2022 Filed Nov 11, 2022 02:30 UTC |
L-5 Healthcare Partners, LLC10% owner · Director by deputization
Segal Paul10% owner · Director by deputization
|
OtherWarrants to Purchase Common Stock · Derivative | 1,000,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001567619-22-019629 · doc1.xml · derivative · entry 3 L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization Segal Paul · CIK 0001427470 · 10% owner · Director by deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,346,032 Underlying: Common Stock · 1,000,000 shares Expires 2023-05-17 F1 · ownership.direct: Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act. F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein. Read SEC document |
| November 09, 2022 Filed Nov 11, 2022 02:30 UTC |
L-5 Healthcare Partners, LLC10% owner · Director by deputization
Segal Paul10% owner · Director by deputization
|
Tax withholdingCommon Stock | 375,790 | $9.31 | $3,498,604.90 |
DisclosureSEC source: 0001567619-22-019629 · doc1.xml · nonDerivative · entry 2 L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization Segal Paul · CIK 0001427470 · 10% owner · Director by deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,866,971 F3 · shares: Represents a "cashless exercise" of outstanding warrants. The reporting person received 624,210 shares of Common Stock on cashless exercise of warrants to purchase 1,000,000 shares of Common Stock. The Company withheld 375,790 shares of Common Stock underlying the warrants for payment of the exercise price, using the VWAP on November 8, 2022 of approximately $9.31, pursuant to the terms of the warrant. F4 · balance_after: Paul Segal separately is the direct beneficial owner of 338,825 shares of Common Stock of the Issuer. F1 · ownership.direct: Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act. F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein. Read SEC document |
| November 09, 2022 Filed Nov 11, 2022 02:30 UTC |
L-5 Healthcare Partners, LLC10% owner · Director by deputization
Segal Paul10% owner · Director by deputization
|
Exercise / conversionCommon Stock | 1,000,000 | $3.50 | $3,500,000.00 |
DisclosureSEC source: 0001567619-22-019629 · doc1.xml · nonDerivative · entry 1 L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization Segal Paul · CIK 0001427470 · 10% owner · Director by deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,242,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · balance_after: Paul Segal separately is the direct beneficial owner of 338,825 shares of Common Stock of the Issuer. F1 · ownership.direct: Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act. F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 17:57 UTC |
Sponsel DavidEVP, SALES
|
SaleCommon Stock | 10,000 | $9.25 | $92,500.00 |
DisclosureSEC source: 0001415889-22-011220 · form4-11092022_051110.xml · nonDerivative · entry 1 Sponsel David · CIK 0001772837 · EVP, SALES 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 566,690 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2022. F2 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.20 to $9.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 17:48 UTC |
Miles PatrickDirector · CEO
|
GrantCommon Stock | 359,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-011092 · form4-11042022_021147.xml · nonDerivative · entry 1 Miles Patrick · CIK 0001289409 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,661,633 F1 · shares: On May 13, 2019, issuer granted the reporting person an incentive award (the "Award") equal to 312,500 times the publicly traded stock price for issuer's common stock at market close on May 13, 2023, which was due and payable to the reporting person in cash on May 14, 2023; provided that the publicly traded stock price for issuer's common stock at market close on May 13, 2023 is equal to or greater than $6.18 per share (representing a 50% increase in the price per share as of the initial grant date). On November 2, 2022, issuer approved an amendment to the Award which: (i) converts the Award from cash payment to payment in fully vested shares of issuer's common stock, subject to satisfaction of the original closing stock price condition; (ii) extends the payment date for the Award to June 30, 2023; and (iii) sets the number of shares of issuer's common stock subject to the Award at 359,375. F1 · balance_after: On May 13, 2019, issuer granted the reporting person an incentive award (the "Award") equal to 312,500 times the publicly traded stock price for issuer's common stock at market close on May 13, 2023, which was due and payable to the reporting person in cash on May 14, 2023; provided that the publicly traded stock price for issuer's common stock at market close on May 13, 2023 is equal to or greater than $6.18 per share (representing a 50% increase in the price per share as of the initial grant date). On November 2, 2022, issuer approved an amendment to the Award which: (i) converts the Award from cash payment to payment in fully vested shares of issuer's common stock, subject to satisfaction of the original closing stock price condition; (ii) extends the payment date for the Award to June 30, 2023; and (iii) sets the number of shares of issuer's common stock subject to the Award at 359,375. Read SEC document |
| September 06, 2022 Filed Feb 3, 2023 22:56 UTC |
Pelizzon David RDirector · 10% owner
|
GiftCommon Stock | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-003915 · doc5.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,145 Read SEC document |
| August 29, 2022 Filed Aug 29, 2022 16:58 UTC |
Mowry David HDirector
|
SaleCommon Stock | 4,370 | $7.85 | $34,304.50 |
DisclosureSEC source: 0001415889-22-009154 · form4-08292022_010814.xml · nonDerivative · entry 1 Mowry David H · CIK 0001414301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,973 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.85 to $7.87, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 17, 2022 Filed Aug 17, 2022 22:39 UTC |
Altman Elizabeth AnnDirector
|
SaleCommon Stock | 8,009 | $9.06 | $72,561.54 |
DisclosureSEC source: 0001415889-22-008802 · form4-08172022_030823.xml · nonDerivative · entry 1 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,431 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.93 to $9.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 17, 2022 Filed Aug 17, 2022 22:32 UTC |
Hunsaker Craig EEVP, PEOPLE/CULTURE & GC
|
SaleCommon Stock | 9,895 | $9.07 | $89,747.65 |
DisclosureSEC source: 0001415889-22-008801 · form4-08172022_030853.xml · nonDerivative · entry 3 Hunsaker Craig E · CIK 0001509282 · EVP, PEOPLE/CULTURE & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,251,174 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 22:32 UTC |
Hunsaker Craig EEVP, PEOPLE/CULTURE & GC
|
SaleCommon Stock | 900 | $9.50 | $8,550.00 |
DisclosureSEC source: 0001415889-22-008801 · form4-08172022_030853.xml · nonDerivative · entry 2 Hunsaker Craig E · CIK 0001509282 · EVP, PEOPLE/CULTURE & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,261,069 Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 22:32 UTC |
Hunsaker Craig EEVP, PEOPLE/CULTURE & GC
|
SaleCommon Stock | 30,000 | $9.70 | $291,000.00 |
DisclosureSEC source: 0001415889-22-008801 · form4-08172022_030853.xml · nonDerivative · entry 1 Hunsaker Craig E · CIK 0001509282 · EVP, PEOPLE/CULTURE & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,261,969 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.50 to $9.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 22:56 UTC |
Sponsel DavidEVP, SALES
|
Tax withholdingCommon Stock | 620 | $8.91 | $5,524.20 |
DisclosureSEC source: 0001415889-22-008574 · form4-08122022_030848.xml · nonDerivative · entry 1 Sponsel David · CIK 0001772837 · EVP, SALES 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 576,690 F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. Read SEC document |
| August 10, 2022 Filed Aug 11, 2022 19:58 UTC |
Pritzker Jennifer N.10% owner
|
PurchaseCommon Stock | 2,000 | $8.04 | $16,080.00 |
DisclosureSEC source: 0000899243-22-028361 · doc4.xml · nonDerivative · entry 4 Pritzker Jennifer N. · CIK 0001850165 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,000 F2 · ownership.nature: These shares are held by the Pritzker Military Foundation. As the sole member of the Pritzker Military Foundation, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of her pecuniary interest therein. Read SEC document |
| August 10, 2022 Filed Aug 11, 2022 19:58 UTC |
Pritzker Jennifer N.10% owner
|
PurchaseCommon Stock | 2,000 | $8.10 | $16,200.00 |
DisclosureSEC source: 0000899243-22-028361 · doc4.xml · nonDerivative · entry 3 Pritzker Jennifer N. · CIK 0001850165 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,200 Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 19:58 UTC |
Pritzker Jennifer N.10% owner
|
PurchaseCommon Stock | 2,100 | $7.85 | $16,485.00 |
DisclosureSEC source: 0000899243-22-028361 · doc4.xml · nonDerivative · entry 2 Pritzker Jennifer N. · CIK 0001850165 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,831 F1 · ownership.nature: These shares are held by the reporting person's spouse, and the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of her pecuniary interest therein. Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 19:58 UTC |
Pritzker Jennifer N.10% owner
|
PurchaseCommon Stock | 2,000 | $7.97 | $15,940.00 |
DisclosureSEC source: 0000899243-22-028361 · doc4.xml · nonDerivative · entry 1 Pritzker Jennifer N. · CIK 0001850165 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,200 Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 18:00 UTC |
Miles PatrickDirector · CEO
|
Tax withholdingCommon Stock | 57,443 | $8.03 | $461,267.29 |
DisclosureSEC source: 0001415889-22-008430 · form4-08092022_060801.xml · nonDerivative · entry 1 Miles Patrick · CIK 0001289409 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,302,258 F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 22:00 UTC |
Howell Kelli MariEVP, CLINICAL STRATEGIES
|
Tax withholdingCommon Stock | 6,050 | $8.03 | $48,581.50 |
DisclosureSEC source: 0001415889-22-008433 · form4-08092022_060817.xml · nonDerivative · entry 1 Howell Kelli Mari · CIK 0001734485 · EVP, CLINICAL STRATEGIES 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,098 F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F2 · balance_after: Includes 2,034 shares acquired under issuer's employee stock purchase plan on May 13, 2022. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 22:00 UTC |
Snider BrianEVP, MARKETING
|
Tax withholdingCommon Stock | 6,805 | $8.03 | $54,644.15 |
DisclosureSEC source: 0001415889-22-008432 · form4-08092022_060812.xml · nonDerivative · entry 1 Snider Brian · CIK 0001702383 · EVP, MARKETING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655,382 F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 22:00 UTC |
Hunsaker Craig EEVP, PEOPLE/CULTURE & GC
|
Tax withholdingCommon Stock | 9,760 | $8.03 | $78,372.80 |
DisclosureSEC source: 0001415889-22-008431 · form4-08092022_060807.xml · nonDerivative · entry 1 Hunsaker Craig E · CIK 0001509282 · EVP, PEOPLE/CULTURE & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,291,969 F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. Read SEC document |
| June 15, 2022 Filed Jun 15, 2022 20:56 UTC |
TULLIS JAMES L LDirector
|
PurchaseCommon Stock | 7,500 | $6.76 | $50,700.00 |
DisclosureSEC source: 0001179110-22-003325 · edgar.xml · nonDerivative · entry 4 TULLIS JAMES L L · CIK 0001230641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,558 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.75 to $6.77, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2022 Filed Jun 15, 2022 20:56 UTC |
TULLIS JAMES L LDirector
|
GrantCommon Stock | 18,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003325 · edgar.xml · nonDerivative · entry 3 TULLIS JAMES L L · CIK 0001230641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,058 F2 · kind: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F2 · shares: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F2 · price: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F2 · balance_after: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 17:52 UTC |
Segal Paul10% owner
|
PurchaseCommon Stock | 50,000 | $6.87 | $343,500.00 |
DisclosureSEC source: 0001140361-22-023209 · form4.xml · nonDerivative · entry 2 Segal Paul · CIK 0001427470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,825 F2 · price: This price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging $6.76 to $6.97, inclusive. The reporting undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 15:27 UTC |
Meynadier MarieDirector
|
GrantCommon Stock | 18,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003355 · edgar.xml · nonDerivative · entry 1 Meynadier Marie · CIK 0001868954 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,218 F1 · security: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 19:31 UTC |
Blackford Quentin S.Director
|
GrantCommon Stock | 18,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003362 · edgar.xml · nonDerivative · entry 1 Blackford Quentin S. · CIK 0001612451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 542,697 F1 · security: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 15:31 UTC |
Mowry David HDirector
|
GrantCommon Stock | 18,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003363 · edgar.xml · nonDerivative · entry 1 Mowry David H · CIK 0001414301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,343 F1 · security: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 15:27 UTC |
MCGINNIS KAREN KDirector
|
GrantCommon Stock | 18,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003356 · edgar.xml · nonDerivative · entry 1 MCGINNIS KAREN K · CIK 0001188264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,206 F1 · security: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 15:28 UTC |
Rydin Jeffrey PDirector
|
GrantCommon Stock | 18,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003357 · edgar.xml · nonDerivative · entry 1 Rydin Jeffrey P · CIK 0001345767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 543,655 F1 · security: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 15:29 UTC |
WOODS WARD W JRDirector
|
GrantCommon Stock | 18,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003359 · edgar.xml · nonDerivative · entry 1 WOODS WARD W JR · CIK 0001196931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,505 F1 · security: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 19:34 UTC |
Barnett AndyDirector
|
GrantCommon Stock | 18,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003367 · edgar.xml · nonDerivative · entry 1 Barnett Andy · CIK 0001934176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,546 F1 · security: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 19:32 UTC |
Altman Elizabeth AnnDirector
|
GrantCommon Stock | 18,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003364 · edgar.xml · nonDerivative · entry 1 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,440 F1 · security: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 19:30 UTC |
Bakst EvanDirector
|
OtherWarrants (right to buy) · Derivative | 400,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003361 · edgar.xml · derivative · entry 4 Bakst Evan · CIK 0001733939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 400,000 shares Expires 2022-06-15 Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 19:30 UTC |
Bakst EvanDirector
|
GrantCommon Stock | 18,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003361 · edgar.xml · nonDerivative · entry 3 Bakst Evan · CIK 0001733939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,087,830 F2 · security: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F2 · kind: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F2 · shares: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F2 · price: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F2 · balance_after: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 19:30 UTC |
Bakst EvanDirector
|
Disposition to issuerCommon Stock | 117,077 | $6.83 | $799,635.91 |
DisclosureSEC source: 0001179110-22-003361 · edgar.xml · nonDerivative · entry 2 Bakst Evan · CIK 0001733939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,069,284 F1 · kind: Shares withheld by issuer to satisfy the exercise price for the warrant shares. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 19:30 UTC |
Bakst EvanDirector
|
OtherCommon Stock | 400,000 | $2.00 | $800,000.00 |
DisclosureSEC source: 0001179110-22-003361 · edgar.xml · nonDerivative · entry 1 Bakst Evan · CIK 0001733939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,186,361 Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 19:30 UTC |
Pelizzon David RDirector · 10% owner
|
GrantCommon Stock | 18,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003360 · edgar.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,395 F1 · security: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 19:29 UTC |
Snider BrianEVP, Marketing
|
Exercise / conversionWarrants (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003358 · edgar.xml · derivative · entry 3 Snider Brian · CIK 0001702383 · EVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2022-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 19:29 UTC |
Snider BrianEVP, Marketing
|
Tax withholdingCommon Stock | 14,634 | $6.83 | $99,950.22 |
DisclosureSEC source: 0001179110-22-003358 · edgar.xml · nonDerivative · entry 2 Snider Brian · CIK 0001702383 · EVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 662,187 F1 · kind: Shares withheld by issuer to satisfy the exercise price for the warrant shares. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 19:29 UTC |
Snider BrianEVP, Marketing
|
Exercise / conversionCommon Stock | 50,000 | $2.00 | $100,000.00 |
DisclosureSEC source: 0001179110-22-003358 · edgar.xml · nonDerivative · entry 1 Snider Brian · CIK 0001702383 · EVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 676,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2022 Filed Jun 15, 2022 20:06 UTC |
Miles PatrickDirector · CEO
|
Tax withholdingCommon Stock | 298,933 | $7.33 | $2,191,178.89 |
DisclosureSEC source: 0001179110-22-003329 · edgar.xml · nonDerivative · entry 1 Miles Patrick · CIK 0001289409 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,359,701 F1 · kind: Shares withheld to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · shares: Shares withheld to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 00:06 UTC |
Hunsaker Craig EEVP, People/Culture & GC
|
SaleCommon Stock | 30,000 | $7.00 | $210,000.00 |
DisclosureSEC source: 0001179110-22-003328 · edgar.xml · nonDerivative · entry 2 Hunsaker Craig E · CIK 0001509282 · EVP, People/Culture & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,301,729 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.84 to $7.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 17:52 UTC |
Segal Paul10% owner
|
PurchaseCommon Stock | 50,000 | $6.95 | $347,500.00 |
DisclosureSEC source: 0001140361-22-023209 · form4.xml · nonDerivative · entry 1 Segal Paul · CIK 0001427470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,825 F1 · price: This price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging $6.84 to $7.1, inclusive. The reporting undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:56 UTC |
TULLIS JAMES L LDirector
|
OtherCommon Stock | 131,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003325 · edgar.xml · nonDerivative · entry 2 TULLIS JAMES L L · CIK 0001230641 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Tullis-Dickerson Partners III, LLC Disclosed balance after: 380,095 F1 · kind: On June 13, 2022, Tullis Dickerson Capital Focus III, LP distributed 600,000 shares to its partners on a pro rata basis (468,130 shares to its limited partners and 131,870 shares to its General Partner, Tullis-Dickerson Partners III, LLC). F1 · shares: On June 13, 2022, Tullis Dickerson Capital Focus III, LP distributed 600,000 shares to its partners on a pro rata basis (468,130 shares to its limited partners and 131,870 shares to its General Partner, Tullis-Dickerson Partners III, LLC). Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:56 UTC |
TULLIS JAMES L LDirector
|
OtherCommon Stock | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003325 · edgar.xml · nonDerivative · entry 1 TULLIS JAMES L L · CIK 0001230641 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Tullis Dickerson Capital Focus III, LP Disclosed balance after: 397,606 F1 · kind: On June 13, 2022, Tullis Dickerson Capital Focus III, LP distributed 600,000 shares to its partners on a pro rata basis (468,130 shares to its limited partners and 131,870 shares to its General Partner, Tullis-Dickerson Partners III, LLC). F1 · shares: On June 13, 2022, Tullis Dickerson Capital Focus III, LP distributed 600,000 shares to its partners on a pro rata basis (468,130 shares to its limited partners and 131,870 shares to its General Partner, Tullis-Dickerson Partners III, LLC). Read SEC document |
| June 13, 2022 Filed Jun 16, 2022 00:06 UTC |
Hunsaker Craig EEVP, People/Culture & GC
|
SaleCommon Stock | 30,000 | $7.31 | $219,300.00 |
DisclosureSEC source: 0001179110-22-003328 · edgar.xml · nonDerivative · entry 1 Hunsaker Craig E · CIK 0001509282 · EVP, People/Culture & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,331,729 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.14 to $7.52, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 10, 2022 Filed Jun 13, 2022 10:07 UTC |
Segal Paul10% owner
|
PurchaseCommon Stock | 200 | $7.10 | $1,420.00 |
DisclosureSEC source: 0001140361-22-022671 · form4.xml · nonDerivative · entry 2 Segal Paul · CIK 0001427470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,825 Read SEC document |
| June 09, 2022 Filed Jun 9, 2022 23:30 UTC |
Berkowitz Mortimer IIIDirector
|
Exercise / conversionWarrants (right to buy) · Derivative | 200,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003278 · edgar.xml · derivative · entry 4 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Porcupine Investment Partners, LLC Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2022-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · ownership.nature: Reporting Person is the managing member of Porcupine Investment Partners, LLC and may be deemed to beneficially own the securities held by Porcupine Investment Partners, LLC. Reporting Person, however, disclaims beneficial ownership of such securities except as to the extent of his pecuniary interest therein. Read SEC document |
| June 09, 2022 Filed Jun 9, 2022 23:30 UTC |
Berkowitz Mortimer IIIDirector
|
Exercise / conversionCommon Stock | 200,000 | $2.00 | $400,000.00 |
DisclosureSEC source: 0001179110-22-003278 · edgar.xml · nonDerivative · entry 2 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Porcupine Investment Partners, LLC Disclosed balance after: 526,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · ownership.nature: Reporting Person is the managing member of Porcupine Investment Partners, LLC and may be deemed to beneficially own the securities held by Porcupine Investment Partners, LLC. Reporting Person, however, disclaims beneficial ownership of such securities except as to the extent of his pecuniary interest therein. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 10:07 UTC |
Segal Paul10% owner
|
PurchaseCommon Stock | 71,129 | $7.18 | $510,706.22 |
DisclosureSEC source: 0001140361-22-022671 · form4.xml · nonDerivative · entry 1 Segal Paul · CIK 0001427470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,625 F1 · price: This price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging $7.11 to $7.31, inclusive. The reporting undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 15:59 UTC |
Berkowitz Mortimer IIIDirector
|
PurchaseCommon Stock | 16,000 | $7.20 | $115,200.00 |
DisclosureSEC source: 0001179110-22-003286 · edgar.xml · nonDerivative · entry 1 Berkowitz Mortimer III · CIK 0001364333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,121 F1 · ownership.direct: Includes shares owned by Reporting Person and shares owned by Reporting Person's spouse. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.